Published in AIDS Weekly, February 9th, 2004
"The overall costs usually are lower for the oral route of administration than for the intravenous route, although the cost to the patient depends on insurance coverage," pharmacists in the United States explained. "Other advantages of the oral route include greater safety and convenience, which may improve patient adherence and quality of life."
"In patients with acquired immunodeficiency syndrome (AIDS), the use of oral ganciclovir instead of intravenous ganciclovir to treat the maintenance phase of CMV retinitis reduced the incidence of neutropenia and sepsis, outpatient and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.